UNSPSC 51144302: Phendimetrazine bitartrate

This classification denotes a cns stimulant and anorexiant with the molecular formula C12H17NO.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6985IP0T80, chemically known as (2s,3s)-3,4-dimethyl-2-phenylmorpholine l-(+)-tartrate, but more generally known as phendimetrazine bitartrate, which bears US NIH Compound Identifier 120608. European Medicines Agency schedules phendimetrazine bitartrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09756MIG.

Most nations, for tariff purposes, schedule phendimetrazine bitartrate under HS 29349100. SMILES: C[C@H]1[C@@H](OCCN1C)C2CCCCC2.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.

UNSPSC 51144302 Phendimetrazine bitartrate is a Commodity code that nominally names a specific pharmaceutical product, but state and local recent procurement activity under this code shows a significant mismatch: the only solicitation tagged to it involves naloxone and drug deactivation systems, not phendimetrazine. The code has limited recent activity in the state and local market, and the tagged opportunity does not align with the code's stated scope. Seminole County, Florida posted an IFB for naloxone and safe drug deactivation systems—a public health and harm-reduction procurement, not a pharmaceutical stimulant purchase. This suggests either a tagging error in the underlying procurement system or that the code is being applied inconsistently across state and local jurisdictions.

Seminole County, Florida is the only issuing body with a recent opportunity tagged to this code. The county's IFB 60459723LAS, posted June 30, 2026, solicited 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The response deadline was July 26, 2023—a date now in the past relative to the current solicitation post date, indicating either a data reporting lag or a stale record. The contract included a two-year initial term with one-year renewal option, E-Verify and drug-free workplace requirements, and potential FEMA funding with associated federal compliance obligations. Given the single entry, thin recent activity, and the disconnect between the code name and the actual procurement scope, this code warrants a skip for business development targeting state and local phendimetrazine sales or related pharmaceuticals.